Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00504894Phase 4Terminated
Phase 4, randomised, double-blind trial of propofol injection (veterinary) (3 arms), sponsored by Weill Cornell Medicine. Primary endpoint: Blood-oxygen-level-dependent Significant Activation Cluster at 90 minutes. Started Mar 2007; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00504894.